CSIMarket
 

Inogen Inc   (INGN)
Other Ticker:  
 

Inogen Inc 's Working Capital Per Sales

INGN's Working Capital and Revenue growth



INGN Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change -29.67 % -13.25 % -10.13 % -10.6 % -8.65 %
Y / Y Revenue Change -20.33 % -19.1 % -10.23 % 15.3 % 13.19 %
Working Capital Per Revenue 0.66 0.68 0.66 0.67 0.71
Total Ranking # 2252 # 2467 # 1640 # 1700 # 1714
Seq. Working Capital Change -20.22 % -4.29 % -2.99 % -5.06 % -1.59 %
Seq. Revenue Change 0.4 % 15.9 % -18.08 % -16.41 % 1.95 %





Comment on INGN's Working Capital Per Revenue in the third quarter 2023
Inogen Inc 's Working Capital Per Revenue in the Q3 2023 sequentially fell to 0.66 below the company average. Due to decrease of revenue year on year in the third quarter 2023 by -20.33%.

Within Healthcare sector 72 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Inogen Inc Working Capital Per Revenue overall ranking has impoved so far in the Q3 2023 to 2252, from total ranking in the second quarter 2023 at 2467.
Working Capital Per Revenue Ranking
Within: No.
Industry # 15
Sector # 73
S&P 500 # 2252


Working Capital Per Revenue Statistics
High Average Low
0.82
0.68
0.55
(Mar 31 2021)   (Dec. 30, 2015)



Financial Statements
Inogen Inc 's Working Capital $ 177 Millions Visit INGN's Balance sheet
Inogen Inc 's Revenues $ 84 Millions Visit INGN's Income Statement
Where are INGN's Sales coming from? Visit INGN's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Evoke Pharma Inc   1.79 
Macrogenics Inc   1.79 
Sarepta Therapeutics Inc   1.78 
Inmed Pharmaceuticals Inc   1.77 
Oncocyte Corporation  1.76 
Fulgent Genetics Inc   1.74 
2seventy Bio Inc   1.73 
Arrowhead Pharmaceuticals Inc   1.72 
Sensus Healthcare Inc   1.72 
The Beauty Health Company  1.69 
Ligand Pharmaceuticals Incorporated  1.69 
Clearpoint Neuro Inc   1.69 
Karyopharm Therapeutics Inc   1.67 
Twist Bioscience Corporation  1.63 
Eargo Inc   1.61 
Amarin Corp Plcuk  1.57 
Point Biopharma Global Inc   1.55 
Mirum Pharmaceuticals Inc   1.53 
Ocular Therapeutix Inc   1.52 
Avita Medical Inc   1.51 
G1 Therapeutics Inc   1.49 
Biomerica Inc   1.48 
Intra cellular Therapies Inc   1.48 
Reflect Scientific Inc   1.48 
Beigene ltd   1.47 
Retractable Technologies inc   1.45 
Marker Therapeutics inc   1.39 
Nuwellis Inc   1.37 
Standard Biotools Inc   1.36 
Revance Therapeutics Inc   1.35 
Date modified: 2023-11-12T12:30:02+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com